References

1. Medicare, Medicaid and CLIA Programs: Regulations Implementing the Clinical Laboratory Improvement Amendments of 1988 (CLIA). Final rule. Fed. Regi. 57:7002, 1992. Available at http://www.fda.gov/ cdrh/clia.

2. Medicare, Medicaid and CLIA Programs; Laboratory Requirements Relating to Quality Systems and Certain Personnel Qualifications; Final Rule (January 24, 2003) Fed. Regi. 68:3640, 2003.

3. American College of Medical Genetics (ACMG). Standards and Guidelines for Clinical Genetics Laboratories. 3rd ed. Avalable at http://www.acmg.net.

4. College of American Pathology. Molecular pathology checklist. Avalable at http://www.cap.org.

5. NCCLS. Molecular Diagnostic Methods for Genetic Diseases; Approved Guideline. NCCLS document MM1-A. NCCLS, Wayne, PA, 2000.

6. McGovern, M., Benach, M., Wallenstein, S., Desnick, R., and Keenlyside, R. Quality assurance in molecular genetic testing laboratories. JAMA 281:835-840, 1999.

7. Hofgartner, W. T. and Tait, J. F. Characteristics of clinical molecular-genetic testing laboratories in the United States. Clin. Chem. 45(8): 1288-1290, 1999.

8. Van Deerlin,V. Personal communication, 2003.

9. Beutler, E., Gelbart ,T., and Kuhl, W. Interference of heparin with the polymerase chain reaction. BioTechniques. 9:166, 1990.

10. Ginocchio, C. C., Wang, X. P., Kaplan, M. H., et al. Effects of specimen collection, processing and storage conditions on stability of human immunodeficiency virus type 1 RNA levels in plasma. J. Clin. Microbiol. 11:2886-2893, 1997.

11. Farkas, D. H., Drevon, A. M., Kiechle, F. L., DiCarlo, R. G., Heath, E. M., Crisan, D. Specimen stability for DNA-based diagnostic testing. Diagn. Mol. Pathol. 5(4): 227-235, 1996.

12. Dicover, R. E., Herman, S. A., Saddiqu, K., Wafer, D., Dillon, M., and Bryson, Y. J. Optimization of specimen-handling procedures for accurate quantitation of levels of human immunodeficiency virus RNA in plasma by reverse transcriptase PCR. J. Clin. Microbiol. 36: 1070-1073, 1998.

13. New York State Department of Health Laboratory, Wadsworth Center. Clinical Laboratory Evaluation Program, Laboratory Standards. Available at http://www.wadsworth.org/labcert/. (accessed February 2002).

14. NCCLS. Clinical Laboratory Technical Procedure Manuals, 4th ed. Approved Guideline GP2-A4.NCCLS Wayne, PA, 2002.

15. Gentra Systems. Purigene DNA Isolation Kit, Gentra Systems, Minneapolis, MN. Available at http://www.gentra.com.

16. Kwok, S. and Higuchi, R. Avoiding false positive with PCR. Nature 339:237-238, 1989.

17. Longo, M. C., Berninger, M. S., and Hurtley, J. L. Use of uracil DNA glycosylase to control carry-over contamination in poly-merase chain reactions. Gene 93:125-128, 1990.

18. Association for Molecular Pathology Statement. Recommendations for in-house development and operation of molecular diagnostic tests. Am. J. Clin. Pathol. 111:449-463, 1999.

19. Shahangian, S., Holmes, E. H., and Taylor, R. Toward optimal PT use. Med. Lab. Observ. 32(4):32-43, 2000.

20. Schwartz, M. K. Genetic testing and the Clinical Laboratory Improvement Amendment of 1988: present and future. Clin. Chem. 45(5):739-745, 1999.

21. The Health Insurance Portability and Accountability Act of 1996 (Public Law 104-191). Standards for Privacy of Individually Identifiable Health Information-45 CFR Parts 160 and 164.

Pregnancy Guide

Pregnancy Guide

A Beginner's Guide to Healthy Pregnancy. If you suspect, or know, that you are pregnant, we ho pe you have already visited your doctor. Presuming that you have confirmed your suspicions and that this is your first child, or that you wish to take better care of yourself d uring pregnancy than you did during your other pregnancies; you have come to the right place.

Get My Free Ebook


Post a comment